Nikfarjam M, Muralidharan V, McLean C, Christophi C
Department of Surgery, Alfred Hospital Melbourne, Victoria, Australia.
ANZ J Surg. 2001 Sep;71(9):529-33. doi: 10.1046/j.1440-1622.2001.02185.x.
Pancreaticoduodenectomy (PD) is considered to be the optimal treatment for ampullary adenocarcinomas. Local resection (LR) is a less invasive and potentially equally effective alternative for cancers with favourable prognostic features. Identification of these prognostic parameters may allow selection of patients suitable for LR.
Twenty-five patients were treated for a primary Vater's ampulla adenocarcinoma at the Alfred Hospital, Melbourne, Australia, between January 1989 and January 2000. Risk factors for cancer recurrence were evaluated and the specific role of LR was defined.
Fourteen patients had PD, five had LR and six had bypass procedures (five biliary stents; one operative bypass). Presenting symptoms included jaundice (64%), abdominal pain (54%) and weight loss (32%). Adenocarcinomas that were resected had a median diameter of 2.5 cm, and were limited to the ampulla in 26% (T1), invaded the duodenal wall in 42% (T2) and infiltrated 2 cm or less into the pancreas in 32% (T1) of cases. Locally resected cancers were confined to the ampulla or invaded the duodenum and recurred in one patient following excision. Six recurrences occurred in total, influenced significantly by T staging (P = 0.009). Patient age, preoperative symptoms, laboratory tests, tumour size, differentiation, ulceration, lymphovascular spread and perineural invasion had no effect on recurrence. Patients undergoing LR had lower morbidity and mortality, reduced blood transfusion requirements and shorter hospital stay than those treated by PD.
T staging predicts the risk of tumour recurrence and can be determined using endoscopic ultrasound. Local resection is a suitable alternative to pancreaticoduodenal resection in patients with T1 and T2 adenocarcinomas with a maximum diameter of 3 cm or less.
胰十二指肠切除术(PD)被认为是壶腹腺癌的最佳治疗方法。对于具有良好预后特征的癌症,局部切除术(LR)是一种侵入性较小且可能同样有效的替代方法。识别这些预后参数可能有助于选择适合LR的患者。
1989年1月至2000年1月期间,澳大利亚墨尔本阿尔弗雷德医院对25例原发性 Vater壶腹腺癌患者进行了治疗。评估了癌症复发的危险因素,并确定了LR的具体作用。
14例患者接受了PD,5例接受了LR,6例接受了旁路手术(5例胆管支架置入;1例手术旁路)。主要症状包括黄疸(64%)、腹痛(54%)和体重减轻(32%)。切除的腺癌中位直径为2.5 cm,26%(T1)局限于壶腹,42%(T2)侵犯十二指肠壁,32%(T1)病例胰腺浸润2 cm或更短。局部切除的癌症局限于壶腹或侵犯十二指肠,1例患者切除后复发。总共发生6次复发,受T分期影响显著(P = 0.009)。患者年龄、术前症状、实验室检查、肿瘤大小、分化程度、溃疡、淋巴管扩散和神经周围浸润对复发均无影响。与接受PD治疗的患者相比,接受LR的患者发病率和死亡率更低,输血需求减少,住院时间更短。
T分期可预测肿瘤复发风险,可通过内镜超声确定。对于最大直径3 cm或更小的T1和T2腺癌患者,局部切除术是胰十二指肠切除术的合适替代方法。